V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240016142 | 240012656 | 1.75 | 67 | Curative (C) | 2016-03-21 | 2016-10-19 | CRIZOTINIB | 2 | N | 240011773 | ATG + BUSULFAN + FLUDARABINE |
| 240016143 | 240015437 | 1.7 | null | Palliative (P) | 2016-02-26 | 2016-03-03 | AML 19 TRIAL | 02 | N | 240012317 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240016144 | 240008743 | null | 64.6 | Adjuvant (A) | 2017-04-07 | 2017-06-29 | CYTARABINE + ETOPOSIDE | null | N | 240012938 | CLADRIBINE |
| 240016145 | 240008746 | null | 70.4 | Palliative (P) | null | 2020-09-21 | DHAP - R | null | N | 240013419 | NHL 2003 |
| 240016146 | 240008755 | 1.66 | 70.2 | Palliative (P) | null | 2019-03-29 | Carboplatin + Docetaxel | 99 | N | 240014317 | VINBLASTINE |
| 240016147 | 240008770 | 0 | null | Neo-adjuvant (N) | 2015-11-14 | 2015-11-18 | CISPLATIN + FLUOROURACIL | N | N | 240015521 | FLUDARABINE |
| 240016148 | 240008779 | 0 | 39.6 | Curative (C) | 2018-10-04 | 2018-10-14 | ALL UKALL2011 Maintenance A1 | 2 | N | 240016111 | LIPOSOMAL CYTARABINE |
| 240016149 | 240012697 | 1.63 | 76.4 | Palliative (P) | 2018-07-07 | 2018-07-08 | Capecitabine (21days) + Carboplatin | N | N | 240017201 | CISPLATIN + FLUOROURACIL |
| 240016150 | 240008796 | 1.63 | 89 | Curative (C) | 2018-06-11 | 2018-06-11 | Ixazomib + Lenalidomide | N | N | 240017293 | CYTARABINE HIGH DOSE |
| 240016151 | 240008802 | 1.62 | 68.7 | Palliative (P) | 2018-05-08 | 2018-05-15 | Carboplatin + Topotecan | N | N | 240017716 | CETUXIMAB |
| 240016152 | 240008806 | 1.59 | 60 | Palliative (P) | null | 2016-09-12 | Capecitabine + Oxaliplatin 14day | N | N | 240018081 | ICE-R |
| 240016153 | 240016338 | 1.65 | 83 | Disease modification (D) | 2016-11-01 | 2018-09-17 | CODOX M | N | N | 240019353 | R-EPOCH |
| 240016154 | 240012717 | null | 78 | Curative (C) | 2018-04-22 | 2018-08-16 | CHOP R + METHOTREXATE | 02 | N | 240020386 | AML18 TRIAL |
| 240016155 | 240012722 | 1.74 | null | Palliative (P) | 2020-05-23 | 2020-05-23 | CISPLATIN + FLUOROURACIL | 02 | N | 240020689 | CARBOPLATIN + DOCETAXEL |
| 240016156 | 240014547 | 1.7 | 62.7 | Curative (C) | 2016-03-04 | 2016-03-25 | REMODLB TRIAL | N | N | 240020856 | CHLORAMBUCIL + OBINUTUZUMAB |
| 240016157 | 240008870 | null | 81 | Palliative (P) | 2017-07-17 | 2017-07-27 | DHAP - R | N | N | 240021767 | TRIPLE INTRATHECAL |
| 240016158 | 240012749 | 1.58 | 81 | Disease modification (D) | 2013-05-12 | 2013-05-13 | AML 19 TRIAL | 2 | null | 240022512 | IRINOTECAN + MDG |
| 240016159 | 240008910 | 1.79 | 57 | Palliative (P) | 2018-06-21 | 2018-06-22 | AML17 TRIAL | 2 | N | 240023200 | ESHAP R |
| 240016160 | 240008913 | null | 79.8 | Curative (C) | 2018-05-18 | 2018-06-24 | IVE | N | N | 240023657 | PMITCEBO-R |
| 240016161 | 240008917 | null | 67.5 | Curative (C) | 2018-09-10 | 2018-09-11 | R CODOX M | 02 | N | 240023735 | CAPECITABINE + OXALIPLATIN |
| 240016162 | 240014566 | 1.84 | 55.1 | 4 | 2016-12-16 | 2016-12-16 | DOXORUBICIN | N | N | 240023933 | CHOEP |
| 240016163 | 240008971 | 1.78 | 71 | Disease modification (D) | 2018-12-25 | 2019-01-06 | Carboplatin + Pemetrexed | N | N | 240030629 | R CODOX-M/ R IVAC |
| 240016164 | 240008973 | 1.6 | 96.8 | Curative (C) | 2017-06-30 | 2017-07-02 | R-GDP | N | N | 240030743 | TOPOTECAN |
| 240016165 | 240008986 | 1.59 | 95.3 | Disease modification (D) | 2015-12-22 | 2016-01-12 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | N | null | 240033328 | mEOC TRIAL |
| 240016166 | 240009005 | 1.52 | 48.8 | Curative (C) | 2018-04-27 | 2018-04-27 | CLADRIBINE | 2 | N | 240006774 | CISPLATIN + ETOPOSIDE + RT |
| 240016167 | 240009008 | null | 85 | Palliative (P) | 2018-06-25 | 2018-07-15 | BENDAMUSTINE + OFATUMUMAB | 02 | N | 240007272 | CISPLATIN + GEMCITABINE |
| 240016168 | 240015486 | 1.6 | 80.25 | Palliative (P) | 2016-11-25 | 2017-08-01 | Cytarabine High Dose | 02 | N | 240015382 | VINORELBINE |
| 240016169 | 240012827 | 1.68 | 74.8 | Palliative (P) | 2017-11-07 | 2018-01-17 | IELSG 32 TRIAL | 1 | N | 240015030 | GEMCITABINE + OXALIPLATIN |
| 240016170 | 240005569 | 1.72 | 55.9 | Palliative (P) | 2018-12-14 | 2019-07-26 | Rituximab | N | N | 240000683 | RITUXIMAB |
| 240016172 | 240005775 | 1.71 | 76 | null | 2019-03-15 | 2019-03-28 | Rituximab | N | N | 240004078 | RITUXIMAB |
| 240016173 | 240005835 | 1.52 | 62.85 | Disease modification (D) | 2016-09-02 | 2017-01-31 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 240004959 | RITUXIMAB |
| 240016174 | 240015033 | 1.52 | 69 | Disease modification (D) | 2014-06-13 | 2014-06-20 | Rituximab | 2 | N | 240006843 | RITUXIMAB |
| 240016175 | 240006210 | null | null | Curative (C) | 2020-06-26 | 2020-06-29 | Rituximab | N | null | 240009601 | RITUXIMAB |
| 240016176 | 240006268 | null | 79 | Palliative (P) | null | 2015-02-05 | Rituximab | N | N | 240010029 | RITUXIMAB |
| 240016177 | 240015080 | 1.6 | 80.55 | null | 2020-06-05 | 2020-06-09 | Rituximab (Maintenance) | N | N | 240010234 | RITUXIMAB |
| 240016178 | 240011414 | 1.7 | 68.3 | Palliative (P) | 2018-04-04 | 2018-04-04 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240010325 | RITUXIMAB |
| 240016179 | 240006356 | 1.5 | 75.6 | Not known (9) | 2015-10-11 | 2016-06-05 | Rituximab (Maintenance) | 02 | N | 240010555 | RITUXIMAB |
| 240016180 | 240006366 | 1.66 | 71.2 | Disease modification (D) | 2016-10-25 | 2016-10-25 | Rituximab | 02 | N | 240010603 | RITUXIMAB |
| 240016181 | 240015094 | 1.7 | 75 | Disease modification (D) | null | 2015-10-10 | Rituximab | N | N | 240010759 | RITUXIMAB |
| 240016182 | 240006428 | 1.6 | 71.8 | Neo-adjuvant (N) | 2016-09-19 | 2016-09-21 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240011049 | RITUXIMAB |
| 240016183 | 240015730 | 1.59 | 55.4 | Disease modification (D) | 2017-01-15 | 2017-11-24 | Rituximab | N | N | 240011092 | RITUXIMAB |
| 240016184 | 240006442 | 1.75 | 81.5 | Disease modification (D) | 2019-01-01 | 2019-04-27 | Rituximab | 02 | N | 240011111 | RITUXIMAB |
| 240016185 | 240006514 | 1.63 | 56.2 | Palliative (P) | 2018-01-28 | 2018-01-28 | Rituximab | 02 | N | 240011479 | RITUXIMAB |
| 240016186 | 240006573 | 1.63 | 54 | Palliative (P) | 2018-04-04 | 2018-05-03 | Rituximab | N | N | 240011846 | RITUXIMAB |
| 240016187 | 240006592 | 1.75 | null | Curative (C) | 2014-09-15 | 2014-09-15 | Rituximab | 02 | N | 240011964 | RITUXIMAB |
| 240016188 | 240006660 | null | 42 | Palliative (P) | 2015-08-29 | 2015-08-29 | Rituximab | N | N | 240017546 | RITUXIMAB |
| 240016189 | 240006706 | null | null | Curative (C) | 2016-04-25 | 2016-12-01 | Rituximab | 2 | N | 240023802 | RITUXIMAB |
| 240016190 | 240006712 | 1.7 | null | Palliative (P) | 2015-06-12 | 2015-06-13 | Rituximab | N | N | 240023841 | RITUXIMAB |
| 240016191 | 240006727 | 1.64 | 75.2 | Curative (C) | 2015-07-03 | 2015-09-05 | Rituximab | N | N | 240023901 | RITUXIMAB |
| 240016193 | 240006773 | null | 0 | Disease modification (D) | 2018-06-04 | 2018-06-19 | Rituximab | null | N | 240024203 | RITUXIMAB |